Article info

Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

Authors

  • Lianne Parkin Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New ZealandPharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Sheila Williams Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • David Barson Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New ZealandPharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Katrina Sharples Pharmacoepidemiology Research Network, University of Otago, Dunedin, New ZealandDepartment of Mathematics and Statistics, University of Otago, Dunedin, New ZealandDepartment of Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Simon Horsburgh Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New ZealandPharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Rod Jackson Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • Jack Dummer Pharmacoepidemiology Research Network, University of Otago, Dunedin, New ZealandDepartment of Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  1. Correspondence to Associate Professor Lianne Parkin; lianne.parkin{at}otago.ac.nz
View Full Text

Citation

Parkin L, Williams S, Barson D, et al
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

Publication history

  • Received November 22, 2020
  • Revised December 3, 2020
  • Accepted December 7, 2020
  • First published January 25, 2021.
Online issue publication 
January 25, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.